Pangraf 0.25mg Capsule

About

Tacrolimus is a potent calcineurin inhibitor and immunosuppressant medication primarily prescribed to prevent organ rejection in patients who have undergone solid organ transplantation, including kidney, liver, and heart transplants. Its mechanism of action involves inhibiting the activity of calcineurin, a phosphatase essential for the activation of T-lymphocytes. By blocking T-cell activation and proliferation, tacrolimus effectively suppresses the immune system's response, thereby preventing the body from recognizing and attacking the transplanted organ as foreign. This targeted immunosuppression is crucial for ensuring the long-term viability and function of the new organ, significantly improving patient outcomes and graft survival rates post-transplant. Due to its narrow therapeutic index, careful and regular monitoring of blood levels is essential to optimize its efficacy while minimizing the risk of dose-related toxicities.

Uses

• Prevention of organ rejection in kidney transplant recipients.
• Prevention of organ rejection in liver transplant recipients.
• Prevention of organ rejection in heart transplant recipients.
• Treatment of organ rejection episodes in some cases.

Directions For Use

Take this capsule orally, usually once or twice daily, as directed by your physician. Swallow whole with water, preferably on an empty stomach.

Benefits

• Effectively prevents organ transplant rejection.
• Improves long-term survival of transplanted organs.
• Reduces the need for other immunosuppressive agents.
• Available in various strengths for precise dosing.
• Helps maintain the quality of life post-transplant.
• Well-established efficacy in transplant medicine.

Side Effects

• Tremor
• Headache
• Diarrhea
• Nausea
• Kidney dysfunction
• High blood pressure
• High blood sugar
• Insomnia
• Hair loss
• Increased risk of infections
• Increased risk of certain cancers
• Electrolyte disturbances

Safety Measures

• Alcohol - Avoid alcohol consumption as it can increase the risk of side effects like liver damage and may interact with tacrolimus metabolism.
• Pregnancy - Tacrolimus should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as it can cross the placenta.
• Breastfeeding - Tacrolimus is excreted into breast milk and can cause adverse effects in the infant; therefore, breastfeeding is generally not recommended.
• Liver - Use with caution in patients with liver impairment, as tacrolimus is extensively metabolized by the liver, requiring dose adjustments and close monitoring.
• Kidney - Tacrolimus can cause nephrotoxicity; close monitoring of kidney function and tacrolimus blood levels is essential, especially in patients with pre-existing kidney conditions.
• Lung - While not a primary concern, tacrolimus can rarely be associated with pulmonary fibrosis; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.